Report on Nonfinancial Matters

The report highlights a 45% reduction in combined Scope 1 and 2 emissions from the 2022 baseline, achievement of carbon neutrality from energy in own operations, and a 2040 net-zero pathway. It reports that Novartis reached 304 million patients globally and introduced access strategies for new treatments. Workforce disclosures include 77 052 headcount and zero fatalities across the separately reported workforce categories. Governance is led by the Board of Directors, with sustainability responsibilities delegated in part to the GSNC.